Understanding Stage 3 Chronic Kidney Disease (CKD): Symptoms, Diagnosis & Management

Stage 3 chronic kidney disease (CKD) signifies mild‑to‑moderate kidney damage, as confirmed by laboratory testing. Patients often begin to notice symptoms such as increased urination frequency and changes in urine colour.

CKD describes permanent, progressive loss of kidney function. Early detection and appropriate care can slow further decline, depending on the disease stage.

Stage 3 sits in the middle of the CKD spectrum. At this point the kidneys have sustained mild to moderate injury.

Diagnosis relies on both clinical symptoms and laboratory results. While existing kidney damage cannot be reversed, timely intervention can prevent additional loss.

The primary diagnostic tool is the estimated glomerular filtration rate (eGFR), derived from a blood test that measures creatinine. eGFR reflects how efficiently the kidneys filter waste.

An eGFR above 90 mL/min/1.73 m² is considered normal; values below 15 indicate stage 5 CKD. Higher eGFR values correspond to better kidney function.

Stage 3 CKD is divided into two sub‑categories based on eGFR:

• Stage 3a: eGFR 45–59 mL/min/1.73 m²
• Stage 3b: eGFR 30–44 mL/min/1.73 m²

The clinical goal is to keep eGFR from falling into the 29–15 range that defines stage 4 CKD.

Symptoms are often subtle in stages 1‑2, but become more apparent in stage 3. Common manifestations include:

• Increased frequency of urination, especially at night
• Foamy or bubbly urine
• Swelling in ankles, feet, or hands
• Fatigue or weakness
• Loss of appetite and unexplained weight loss

If you experience any of these signs, contact a healthcare professional promptly. Even when symptoms overlap with other conditions, a combination of them warrants medical evaluation.

Patients previously diagnosed with stage 1 or 2 CKD should also seek follow‑up care, as progression can occur silently.

It is possible to receive a stage 3 diagnosis without prior CKD history because earlier stages often lack noticeable symptoms.

To confirm stage 3 CKD, clinicians typically order:

• Blood pressure measurement
• Urine analysis
• Blood tests for creatinine and eGFR calculation
• Imaging studies (e.g., ultrasound) to assess kidney structure

Although CKD is incurable, stage 3 offers a critical window to halt or slow progression toward kidney failure. Treatment plans combine medication, dietary adjustments, and lifestyle changes.

Stage 3 Kidney‑Disease Diet

The kidneys regulate waste removal and electrolyte balance, so dietary choices can lessen their workload.

Prioritise whole, minimally processed foods—fresh fruits, vegetables, whole grains, and lean proteins—over packaged convenience items.

Protein intake may be modestly reduced under a dietitian’s guidance. If blood potassium is elevated, limit high‑potassium foods such as bananas, potatoes, and tomatoes.

Similarly, sodium restriction is advised when blood pressure or serum sodium is high; avoid overly salty foods and added table salt.

Weight loss can occur in advanced CKD due to reduced appetite, increasing the risk of malnutrition. If appetite is low, aim for smaller, more frequent meals to meet caloric and nutrient needs.

Medical Treatment

Management of stage 3 CKD commonly involves prescription medications targeting underlying conditions and CKD‑related complications.

For patients with type 2 diabetes, finerenone (brand name Kerendia) may be prescribed to lower the risk of eGFR decline, progression to end‑stage kidney disease, and cardiovascular events.

Additional drugs may address CKD sequelae:

• Iron supplements for anemia
• Calcium or vitamin D analogues to protect bone health
• Statins or other lipid‑lowering agents
• Diuretics to control fluid buildup (edema)

Complementary lifestyle measures that support kidney health include:

• Exercise: At least 30 minutes of moderate activity on most days, as approved by your clinician.
• Blood‑pressure control: Aim for ≤130/80 mm Hg to reduce kidney stress.
• Stress reduction: Prioritise quality sleep, mindfulness practices, and regular relaxation.
• Smoking cessation: Discuss evidence‑based quitting strategies with your doctor.

The overarching objective is to prevent further loss of kidney function. While existing damage cannot be undone, slowing progression at stage 3 greatly improves long‑term outcomes compared with later stages.

Early, well‑managed stage 3 CKD is linked to a longer life expectancy. A 2012 analysis estimated that a 40‑year‑old with stage 3a CKD could expect about 24.5 additional years, whereas stage 3b was associated with roughly 14.5 extra years. Risk of progression rises with age at diagnosis.

In the same study, roughly half of 347 participants with stage 3 CKD advanced to stages 4‑5 within ten years, underscoring the importance of vigilant care.

More recent research (2017) notes improved predictive models but also highlights a scarcity of up‑to‑date long‑term data, making precise life‑expectancy forecasts challenging.

Complications such as cardiovascular disease, anemia, and bone fractures can further influence survival, reinforcing the need for comprehensive management.

Stage 3 CKD is often first identified when symptoms appear. Although the condition cannot be cured, early detection and proactive treatment can substantially lower the risk of progression to kidney failure and associated complications.

Collaborating closely with a nephrologist and adhering to prescribed lifestyle changes empowers many individuals to maintain stable kidney function and quality of life.